THE VALUE OF TUMOR MARKERS IN PULMONARY TUBERCULOSIS.
##plugins.themes.academic_pro.article.main##
Abstract
Background : In thoracic oncology, no tumor marker has yet shown sufficient sensitivity nor specificity to be usefull for lung cancer diagnosis. However, in some cases, monitoring of tumor marker blood levels provides useful evaluation of response to specific treatment and assessment of infracfinical tumor progression.
Aim : To determine the value of umor markers in pulmonary tuberculosis.
Methods : A prospective study was conducte in our department during 2 years 2005 through 2007. We included 40 men who presented confirmed pulmonary tuberculosis. Before starting antituberculous chemotherapy, serum assays were practiced for the following tumor markers: NSE, CA 12.5, ACE and Cyfra 21.1.
Results : Mean age was 37,12 years (17-81). The levels of NSE were high in 91,66% of cases with an average value of 29,22 μg/l (2,24 X normal). This highest sensitivity was superior to those of other tumor markers: 55,55% for CA125, 28,94% for ACE and 7,6% for Cyfra 21.1. Analysis of the levels of NSE according to age, tobacco consumption, delay of consultation, type of the pulmonary lesions and negativation delay in smear did not show any significant difference, whereas levels of CA 125 were higher in bilateral lesions (P=0,05).
Conclusion : The highest sensitivity of the NSE in pulmonary tuberculosis, with no neoplastic pathology could be interesting for diagnosis of smear negative tuberculosis, with small amounts of bacilli.
Keywords:
Pulmonary tuberculosis, tumor markers, NSE, CA 125##plugins.themes.academic_pro.article.details##
References
- Menard O, Dousset B, Jacob C. Le dosage des marqueurs Tumoraux dans le liquide de lavage broncho-alvéolaire en cancérologie broncho-pulmonaire. Immunoanal Biol Spec 1992; 35:23-27.
- Société de Pneumologie de Langue Française. Recommandations concernant l'utilisation des marqueurs tumoraux dans la prise en charge des cancers bronchiques primitifs. Cancérologie Aujourd'hui 1997; 6:293-307.
- Porcel JM, Vives M, Esquerda A, Salud A, Perez B, Panadero FR. Use of a Panel of Tumor Markers (Carcinoembryonic Antigen, Cancer Antigen 125, Carbohydrate Antigen 15-3, and Cytokeratin 19 Fragments) in Pleural Fluid for the Differential Diagnosis of Benign and Malignant Effusions. Chest 2004; 126:1757-1763.
- Ghayumi SM, Mehrabi S, Doroudchi M, Ghaderi A. Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients. Pathol Oncol Res 2005; 11:236-241.
- Villena V, López-Encuentra A, Echave-Sustaeta J, MartÃn-Escribano P, Ortuño-de-Solo B, Estenoz-Alfaro J. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients. Cancer 1996; 78:736-740.
- Pichon MF. Rôle des marqueurs tumoraux dans le comportement biologique de tumeurs solides. Imm Biol Spec 2004; 19:241-249.
- Pichon MF, Eche N, Basuyau JP, Riedinger JM. Surveillance biologique en cancérologie : problèmes rencontrés avec les dosages de marqueurs tumoraux. Imm Biol Spec 2007; 22:34-40.
- Thakur V, Mukherjee U, Kumar K. Elevated serum cancer antigen 125 levels in advanced abdominal tuberculosis. Med Oncol 2001; 18:289-291.
- Çorapçioglu F, Güvenç BH, Sarper N, Aydogan A, Akansel G, Arisoy ES. Peritoneal tuberculosis with elevated serum CA 125 level mimicking advanced ovarian carcinoma in an adolescent. Turk J Pediatr 2006 ; 48:69-72.
- Yilmaz A, Ece F, Bayramgürler B, Akkaya E, Baran R. The value of Ca 125 in the evaluation of tuberculosis activity. Respir Med 2001; 95:666-669.